Navigation Links
A mother at 63: oldest in UK!

Dr Patricia Rashbrook, the psychologist and the oldest mother in UK, from Lewes in East Sussex, has two grown-up children but has recently remarried //and undergone fertility treatment. She gave the statement that this child had been given serious thought.

She and her husband John Farrant made a joint statement, "We wish to emphasise that this has not been an endeavour undertaken lightly or without courage. A great deal of thought has been given to planning and providing for the child's present and future well-being, medically, socially and materially. We are very happy to have given life to an already much-loved baby, and our wish now is to give him the peace and security he needs. We will therefore welcome a return to an undisturbed family life, in order that the well-being of both mother and child may continue to be promoted. We have greatly valued the warm support shown to us by family, friends and colleagues."

The Italian doctor Severino Antinori, who runs a private fertility clinic in Rome, first made headlines in 1994 by helping a post-menopausal 63-year-old woman become pregnant with donor eggs and hormones. He is the doctor who has treated the psychologist.

But it also has a controversial angle.

"It is extremely difficult for a child to have a mother who is as old as a grandmother would be. It is just that consumer society that wants absolutely everything, and never stops to think that a child is not a product. She is being selfish and sometimes greater love is saying no,” said. Josephine Quintavalle. She is from Comment on Reproductive Ethics (Core). She added, “You cannot buy life expectancy - that is the most important," she said. "It is a very worrying development. I do not think that maternal love or the welfare of a child should be equated to financial well-being or a degree."

On the flip side in her defence came, former Lewes neighbour Paul Pyant said, “ Dr Rashbrook had brought up two happy stab
'"/>




Page: 1 2

Related medicine news :

1. Acupuncture May Help Chemotherapy Side Effects
2. Allergies are related to mothers menses
3. Chemotherapy Pill Has Fewer Side Effects Than IV
4. Boys reduced mothers life expectancy
5. Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy"
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Baby born to SARS mother is healthy
8. Therapy Boosts Chemotherapy Effects
9. Chemotherapy Effective for Bladder Cancer
10. New Method Of Delivering Chemotherapy
11. The Benefits Of Chemotherapy For Women With Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: mother oldest

(Date:12/1/2008)... EXTON, Pa., Dec. 1 Vir...unced that the company submitted a supplemental,B...od and Drug Administration,(FDA) for Cinryze(TM) ...cks of,hereditary angioedema (HAE). , The ... data from a pivotal,Phase 3 acute treatment stud...
(Date:12/1/2008)... Alcohol, nicotine use, personality illnesses com...althDay News) -- Psychiatric disorders are common ...eek treatment, a new report shows. , To reach t...ore than 5,000 respondents, aged 19 to 25, who too...ohol and Related Conditions. , The study found ...
(Date:12/1/2008)... , A new analysis of the National Cancer Institut...in five older women experience delayed or incomple... surgery, and that this suboptimal care can lead t...eill Cornell Medical College and colleagues found ...early 8,000 breast cancer registry patients aged 6...
(Date:12/1/2008)... WASHINGTON, Dec. 1 /PRNewswire-USNewswire/ -- ...e release of a model state legislative resolution ...). AUL urges state legislatures to adopt the reso...ssions. , , Dr. Charmaine Yoest, AUL Presid...ice Act, endangers women,s health. It protects an...
Breaking Medicine News(10 mins):Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 2Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 3Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 4Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 5Health News:Few Young Adults Seek Treatment for Psych Disorders 2Health News:Delays in radiation therapy lead to increased breast cancer recurrence 2Health News:Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA) 2
...k we had carried a story about Wal-mart’s foray in... a pilot project which involved the lease of medic... 76 clinics actively functioning at the Wal mart s...uring the meeting of the 4th Annual World Health C...
...nd busier an NHS hospital is, the higher the MRSA ...versity Business School has revealed. The impact...MRSA infections in NHS hospitals study looked at h... imposed by hospital insurers — and the premium di...
...st vaccination of sixth-grader girls to prevent ce...-Texas Governor Rick Perry. //The move sees that T...ixth-grade girls to be vaccinated against a sexual...al cancer. Yesterday, the Texas House gave the go...
...bility and resources for public health and tacklin...cils rather than with the NHS, argues an expert in...m University says that partnerships between local ...d then become a true meeting of the two sides of h...
Other Medicine News:Health News:Better Risk Management Could Cut MRSA Infection Rates 2Health News:Local Councils Should Be Responsible for Tackling Health Inequalities 2
(Date:12/1/2008)...uled for Tuesday, December 9 at 11:00 am ET to Dis...OUTH SAN FRANCISCO, Calif., Dec. 1 /PRNewswire-F...: SNSS ), a biopharmaceutical company focused on...logy therapeutics, today announced new data from i...(AML) will be presented during the 50th American S...
(Date:11/28/2008)...ovember 28 German biotech company,...ialized HIV monitoring and,AIDS patient follow-up.... In,the year 2008, 2.5 million patient tests hav...ghly affordable "CyFlow" system, supporting alread.... Due to introduction of the,Partec innovation, t...
(Date:11/26/2008)...bjects , , FRANKLIN, Mass., Nov. 26 /PRNews...Board: PLCSF) announced today that it has received...tration (FDA) for its U.S. pivotal trial to study ...em(TM) and associated therapy in the prevention o...he FDA also approved PLC,s request to expand their...
(Date:11/25/2008)...if., Nov. 25 Poniard,Ph...ceutical company focused on,innovative oncology t...g,strategic alternatives for its preclinical rese...cus its resources on the clinical development of p...port the initial commercialization of,picoplatin ...
Breaking Medicine Technology:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Liver Transplant Patients at Higher Cancer Risk 27261 1Liver Transplant Patients at Higher Cancer Risk 27261 2PURE Bioscience to Announce Fourth Quarter and Fiscal 2008 Results 8212 1PURE Bioscience to Announce Fourth Quarter and Fiscal 2008 Results 8212 2Hologic Inc To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday November 11 2008 27255 1Hologic Inc To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday November 11 2008 27255 2Children 26apos 3Bs National Experts Presenting at American Academy of Pediatrics Conference 27252 1Children 26apos 3Bs National Experts Presenting at American Academy of Pediatrics Conference 27252 2
...ournal of Clinical Oncology -, NEW YORK, July 06, ...e II study - which will be published in the August...y (JCO) and are now,available as an Early Release ...o.org/">www.jco.org - demonstrate that,ixabepilon...compound, has activity in patients with metastatic...
...5, an Investigational NNRTI,from Tibotec, YARDLEY,...ongoing Phase 3 studies (DUET-1 and DUET-2) showed...mented non-nucleoside reverse,transcriptase inhibi... reached an undetectable viral load (defined as ac...A copies/mL) with,TMC125 (etravirine), Tibotec,s i...
Other Medicine Technology:Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 2Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 3Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 4TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 3TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 4
11.5 mm curved hook. Flat serrated handle with polished finish. Overall length: 5.9 inches.
Designed for manipulating one piece lenses. The "Y: hook is excellent for capturing haptics and centering the lens. Straight shaft with "Y" shaped tip. Round knurled handle with dull finish. Overall
0.2 mm Sinskey hook with shaft angled 45 degrees, 10 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches.
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches.
Medicine Products: